Cited by 1,589COVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction

The DOI matches its Crossref record; 23 of the 27 references it cites were found in a registry or an index.

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Open access

Dai, Mengyuan, Liu, Dianbo, Liu, Miao, Zhou, Fuxiang, Li, Guiling, Chen, Zhen, Zhang, Zhian, You, Hua, Wu, Meng, Zheng, Qichao, Xiong, Yong, Xiong, Huihua, Wang, Chun, Chen, Changchun, Xiong, Fei, Zhang, Yan, Peng, Yaqin, Ge, Siping, Zhen, Bo, Yu, Tingting, Wang, Ling, Wang, Hua, Liu, Yu, Chen, Yeshan, Mei, Junhua, Gao, Xiaojia, Li, Zhuyan, Gan, Lijuan, He, Can, Li, Zhen, Shi, Yuying, Qi, Yuwen, Yang, Jing, Tenen, Daniel G., Chai, Li, Mucci, Lorelei A., Santillana, Mauricio, Cai, Hongbing·2020·Cancer Discovery

DOI 10.1158/2159-8290.cd-20-0422PMC PMC7309152

Open this paper in CoChat — free account Open PDF

Abstract

Abstract The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematologic cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. Patients with nonmetastatic cancer experienced similar frequencies of severe conditions to those observed in patients without cancer. Patients who received surgery had higher risks of having severe events, whereas patients who underwent only radiotherapy did not demonstrate significant differences in severe events when compared with patients without cancer. These findings indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak. Significance: Because this is the first large cohort study on this topic, our report will provide much-needed information that will benefit patients with cancer globally. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients. This article is highlighted in the In This Issue feature, p. 747

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-20-0422

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citation
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citation
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Self-citation
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Multiple myeloma
Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,040

Show all 27 references

Sorted by citations

Items 901–1,000 of 1,001

Prevalence and risks of severe events for cancer patients with COVID-19 infection: a systematic review and meta-analysisPreprint
Su, Q., Hu, J., Lin, H., Zhang, Z., Zhu, E. C., Zhang, C., Wang, D., Gao, Z., & Cao, B. (2020) · medRxiv · doi:10.1101/2020.06.23.20136200 · Cited by 4
Self-citation
COVID-19-Related Symptoms Among Cancer Patients and Healthcare Workers— First Results From the PAPESCO-19 Prospective Cohort StudyPreprint
Zhou, K., Blanc-Lapierre, A., Seegers, V., Boisdron‐Celle, M., Bigot, F., Bourdon, M., Mahammedi, H., Lambert, A., Campone, M., Bellanger, M. M., et al. (2021) · Preprints.org · doi:10.20944/preprints202103.0292.v1 · Cited by 4
Vaccination in Oncology Patients: Evidence, Clinical Challenges, and Future Directions
Agostara, A. G., della Torre, S., Bella, S. D., Pelliccione, M., Candido, P., Smiroldo, V., Roazzi, L., Ciarlo, G., Toniolo, D., Zannier, F., et al. (2026) · Vaccines · doi:10.3390/vaccines14030250 · Cited by 3
Clustering Diseases in Cancer and Health Organization: What Is the Gold-Standard Approach?
Ciarambino, T., Crispino, P., Para, O., & Giordano, M. (2022) · BioMed · doi:10.3390/biomed2030023 · Cited by 3
Methodological Considerations on COVID-19 Mortality in Cancer Patients: A Systematic Review and Meta-Analysis
Zewde, M. G., Alpert, N., & Taioli, E. (2022) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkac063 · Cited by 3
The Experience of COVID-19 in a Sample of Gynecological Cancer Patients Undergoing Chemotherapy: A Focus on the Psychological Implications
Perego, G., Mattei, V. E. D., Mazzetti, M., Milano, F., Gatti, C., Rancoita, P. M. V., Taranto, P., Rabaiotti, E., Cioffi, R., & Candiani, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20053851 · Cited by 3
Effect of chronic diseases on willingness to receive the second COVID-19 vaccine booster dose among cancer patients: A multicenter cross-sectional survey in China
Li, M., Ren, Y., Liu, P., Wang, J., Wang, Y., Xu, J., & Yang, J. (2023) · American Journal of Infection Control · doi:10.1016/j.ajic.2023.11.011 · Cited by 3
Self-citation
Impact of COVID-19 on Cancer Patients: An Experience From a Tertiary Care Center in Northeast India
Kumar, S., Singh, B. K., Dey, B., Jagtap, V. K., Verma, S., & Nongkynrih, A. (2024) · Cureus · doi:10.7759/cureus.52247 · Cited by 3
Response to Savolitinib in a Patient with Advanced Poorly Differentiated Lung Carcinoma Positive for a Novel EML4-MET Gene Fusion
Ouyang, G., Shu, P., Xue, Y., Luo, F., & Li, Y. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s442685 · Cited by 3
Autopsy findings in cancer patients infected with SARS-CoV-2 show a milder presentation of COVID-19 compared to non-cancer patients
Kocsmár, É., Kocsmár, I., Elamin, F., Pápai, L., Jakab, Á., Várkonyi, T., Glasz, T., Rácz, G. A., Pesti, A., Danics, K., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01163-7 · Cited by 3
Differences in Characteristics, Treatments, and Mortality of Patients with COVID-19 Between 2022 and 2020–2021
Aso, S., Ono, S., Michihata, N., Uemura, K., & Yasunaga, H. (2024) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2024.272 · Cited by 3
Safety of Nirmatrelvir-Ritonavir Administration in Children With Immunodeficiency and/or Comorbidities With SARS-CoV-2 Infection: A Retrospective Clinical Report
Bernardi, S., Roversi, M., Torelli, A., Musolino, A., Nicastri, E., Palma, P., Rossi, P., Vallesi, L., Corsetti, T., Lancella, L., et al. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004657 · Cited by 3
Efficacy of Ayurvedic treatment given to cancer patients in the prevention of COVID-19 – A Retrospective Cohort Study at Integrated Cancer Treatment and Research Centre, Wagholi
Sardeshmukh, S., Deshmukh, V. V., Gupta, V. S., Godse, V., Gujar, S., Kulkarni, S., Dalvi, S., Sardeshmukh, N., Sardeshmukh, B., Bhuvad, S., et al. (2025) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2024.101045 · Cited by 3
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies
Gallo, M., Lasagna, A., Renzelli, V., Morviducci, L., Cortellini, A., Monami, M., Marino, G., Gori, S., Verzè, M., Ragni, A., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02586-5 · Cited by 3
Considerations for cancer immunotherapy during the COVID ‐19 pandemic
Kanjanapan, Y., & Yip, D. (2020) · The Medical Journal of Australia · doi:10.5694/mja2.50805 · Cited by 3
COVID-19 Pandemic Preparedness and Mitigation Plan
Alfadda, A. A., Albilali, A., Alqurtas, E. M., Alharbi, A., Ekhzaimy, A. A., Muayqil, T. A., Bedaiwi, M. K., Barry, M. A., Azzam, N. A., Aljebreen, A., et al. (2021) · Journal of Nature and Science of Medicine · doi:10.4103/jnsm.jnsm_109_20 · Cited by 3
Safeguarding COVID-19 and cancer management: drug design and therapeutic approach
Thorat, N. D., Pricl, S., Parchur, A. K., Somvanshi, S. B., Li, Q., Umrao, S., & Townley, H. E. (2021) · Open Research Europe · doi:10.12688/openreseurope.13841.1 · Cited by 3
COVID-19-Related Information Sources, Behavioral Changes, and Adherence to Social Distancing Among Adolescents and Young Adults with Cancer
Yan, A. P., Howden, K., Glidden, C., Romanescu, R. G., Scott, I., Deleemans, J. M., Chalifour, K., Eaton, G., Gupta, A. A., Bolton, J. M., et al. (2021) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2021.0126 · Cited by 3
The Impact of Socioeconomic Variables Status on Bladder Cancer Treatment Outcomes during the COVID-19 Pandemic
Barki, C., Rahmouni, H. B., & Labidi, S. (2021) · OALib · doi:10.4236/oalib.1107921 · Cited by 3
Capillary leak syndrome in COVID-19 and post COVID-19 vaccines
(2021) · European Journal of Gynaecological Oncology · doi:10.31083/j.ejgo4205126 · Cited by 3
Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence
Gupta, T., Debele, T. A., Wei, Y., Gupta, A., Murtaza, M., & Su, W. (2022) · Cancers · doi:10.3390/cancers14010213 · Cited by 3
Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders
Glenthøj, A. B., Jakobsen, L. H., Bjørn, M. E., Poulsen, C. B., Sengeløv, H., Severinsen, M. T., Qvist, K., Overgaard, U. M., Ahmad, S. A., Rewes, A., et al. (2022) · Acta Oncologica · doi:10.1080/0284186x.2022.2026464 · Cited by 3
Patients’ expectations of preventive measures of medical institutions during the SARS-CoV-2 pandemic in Germany in women with an increased risk of breast and ovarian cancer: a cross-sectional, web-based survey
Schwab, R. M., Droste, A., Stewen, K., Brenner, W., Schmidt, M., & Hasenburg, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060038 · Cited by 3
Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients
Moghimi, M., Jozpanahi, M., Khodadadi, K., Saeed, S. P., Pirsaraei, S. V. A., & Jalili, N. (2022) · European Journal of Translational Myology · doi:10.4081/ejtm.2022.10582 · Cited by 3
Clinical presentation and in-hospital prognosis of lung cancer patients presenting with suspected and confirmed COVID-19
Peixoto, D., Callia, J. P. B., Bittencourt, M. S., Generoso, G., Anastacio, V. M., Alves, J. L., da Silva, T. L., Belizario, J. D. C., Araújo, B. L. M., Ho, W., et al. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e12140 · Cited by 3
Impact of high neutrophil‐to‐lymphocyte ratio on survival in hospitalized cancer patients with COVID ‐19
Díaz‐Couselo, F. A., Flagel, S., Nicolini, C., Halac, S., Manzano‐León, N., Aguirre, M., Rébora, J., Valle, S., Noro, L., Mohindroo, C., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5426 · Cited by 3
Naso-oropharyngeal microbiome from breast cancer patients diagnosed with COVID-19
Viana, M. C., Curty, G., Furtado, C., Singh, B., Bendall, M. L., Viola, J. P. B., de Melo, A. C., Soares, M. A., & Moreira, M. Â. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1074382 · Cited by 3
COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome
Rahmanuddin, S., Jamil, A., Chaudhry, A. A., Seto, T. C., Brase, J., Motarjem, P. M., Khan, M., Tomasetti, C., Farwa, U., Boswell, W. D., et al. (2023) · Cancers · doi:10.3390/cancers15030651 · Cited by 4
Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China
An, J., Lin, X., Xie, B., Tung, T., & Zhu, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2165705 · Cited by 3
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms
Kobayashi, M., Mori, A., Onozawa, M., Tsukamoto, S., Senjo, H., Ishio, T., Yokoyama, E., Kanaya, M., Izumiyama, K., Saito, M., et al. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05142-4 · Cited by 3
Insights into the Impact of Hesitancy on Cancer Care and COVID-19
Visweshwar, N., Rico, J. F., Ayala, I. A., Jaglal, M. V., Laber, D. A., Ammad-ud-din, M., Sokol, L., Sotomayor, E. M., & Manoharan, A. (2023) · Cancers · doi:10.3390/cancers15123115 · Cited by 3
Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine
Larbre, V., Romain‐Scelle, N., Reymond, P., Ladjouzi, Y., Herledan, C., Caffin, A. G., Baudouin, A., Maire, M., Maucort‐Boulch, D., Ranchon, F., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04971-0 · Cited by 3
The impact of COVID ‐19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score‐matched analysis
Ulanja, M. B., Beutler, B. D., Asafo-Agyei, K. O., Governor, S., Edusa, S., Antwi‐Amoabeng, D., Ulanja, R. N., Nteim, G. B., Amankwah, M., Neelam, V., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6355 · Cited by 3
REVIEW OF SARS-CORONAVIRUS-2 REPERCUSSIONS ON THYROID GLAND IN THE CONTEXT OF HYPERTHYROIDISM
Singh, S. V., Monika, Mazumder, R., & Mazumder, A. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i5.47937 · Cited by 3
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
Agbarya, A., Sarel, I., Ziv‐Baran, T., Schwartz, O., Sheikh‐Ahmad, M., Saiegh, L., Swaid, F., Shechtman, Y., Kozlener, E., Khoury, R., et al. (2023) · Diseases · doi:10.3390/diseases11040128 · Cited by 2
COVID-19 in Patients with Melanoma: A Single-Institution Study
Anastasopoulou, A. N., Diamantopoulos, P. T., Kouzis, P., Saridaki, M., Sideris, K., Samarkos, M., & Gogas, H. J. (2023) · Cancers · doi:10.3390/cancers16010096 · Cited by 3
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer
Rago, V., Bossio, S., Lofaro, D., Perri, A., & Agostino, S. D. (2023) · Life · doi:10.3390/life14010052 · Cited by 3
ACE2: the node connecting the lung cancer and COVID-19
Yan, L. (2024) · American Journal of Cancer Research · doi:10.62347/xjve4569 · Cited by 3
Clinical characteristics and prognostic factors of COVID-19 infection among cancer patients during the December 2022 – February 2023 Omicron variant outbreak
Liu, L., Liao, Y.-W., Yu, X., Rong, L., Chen, B.-G., Chen, G., Zeng, G.-K., & Yang, L. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1401439 · Cited by 4
Risk of COVID-19 infection in patients with NSCLC receiving EGFR-TKI targeted therapy during the first wave in China
Huang, P., Liao, L.-M., Zhao, J., Luo, C. H., Yi, Y.-L., Chen, Y., & Huang, L. (2024) · Journal of International Medical Research · doi:10.1177/03000605241281907 · Cited by 3
Self-citation
State of Knowledge About Thyroid Cancers in the Era of COVID-19—A Narrative Review
Bronowicka-Szydełko, A., Rabczyński, M., Dumas, I., Fiodorenko-Dumas, Ż., Wojtczak, B., Kotyra, Ł., Kustrzeba−Wójcicka, I., Lewandowski, Ł., Ponikowska, B., Kuzan, A., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12122829 · Cited by 3
The COVID-19 pandemic and clinical characteristics of colorectal cancer: a multicenter retrospective study
Han, Y. D., Bae, S. U., Kim, W. R., Lim, D. R., & Kim, C. W. (2025) · Scientific Reports · doi:10.1038/s41598-025-93349-y · Cited by 3
Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care
Kelkar, A. H., & Cogle, C. R. (2020) · Healthcare · doi:10.3390/healthcare8030214 · Cited by 4
Analysis of clinical features of COVID-19 in cancer patients
Cheng, W., Ke, Y., Yang, G.-Y., Sun, H., Chen, Y., Ying, R.-Y., Zeng, X.-H., Shen, D. H., Tang, K., Xu, K. L., et al. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1810313 · Cited by 3
Self-citation
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
Wong, W., Brieva, C., May, M. S., Gambina, K., Whittier, S., Hod, E. A., Pellicciotta, I., Pan, S. S., Hu, J., Abbott, M., et al. (2020) · Seminars in Oncology · doi:10.1053/j.seminoncol.2020.11.001 · Cited by 3
Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID-19
Shipe, M. E., Baechle, J. J., Deppen, S. A., Gillaspie, E. A., & Grogan, E. L. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-08101-6 · Cited by 3
“Door to Treatment” Outcomes of Cancer Patients during the COVID-19 Pandemic
Ak, N., & Vatansever, S. (2020) · Chemotherapy · doi:10.1159/000511884 · Cited by 3
Clinical Determinants Differentiating the Severity of SARS-CoV-2 Infection in Cancer Patients: Hospital Care or Home Recovery
Lin, D. D., Wu, Y., Toom, S., Sheth, N., Becker, K. D., Burdette-Radoux, S., D'Silva, J., Huang, Y., Lipshitz, J., Meghal, T., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.604221 · Cited by 3
Outcomes of head and neck cancer management from two cancer centres in Southern and Northern Europe during the first wave of COVID-19
Tagliabue, M., Russell, B. A., Moss, C. L., Berardinis, R. D., Chu, F., Jeannon, J., Pietrobon, G., Haire, A., Grosso, E., Wylie, H., et al. (2021) · Tumori Journal · doi:10.1177/03008916211007927 · Cited by 3
Preliminary Study on Associated Risk Factors of Mortality Due to COVID-19 Pandemic in Malaysia
Wahil, M. S. A., Jaáfar, M. H., Ismail, R., Chua, S. P., Jeevananthan, C., Sandhu, R. S., Madrim, M. F., & Haddi, A. A. A. (2021) · International Electronic Conference on Environmental Research and Public Health (ECERPH) · doi:10.3390/ecerph-3-09022 · Cited by 3
Can the host immune response against SARS-CoV2 also cause an anticancer effect?
Kahraman, S., Akıncı, M. B., Şendur, M. A. N., & Yalçın, B. (2021) · Medical Oncology · doi:10.1007/s12032-021-01533-7 · Cited by 3
Suggested Modifications to the Management of Patients With Breast Cancer During the COVID-19 Pandemic: Web-Based Survey Study
Elsamany, S. A., ElBaiomy, M. A., Zeeneldin, A. A., Tashkandi, E. M., Hassanin, F., Abdelhafeez, N., Al-Shamsi, H. O., Bukhari, N., & Elemam, O. (2021) · JMIR Cancer · doi:10.2196/27073 · Cited by 3
Breast cancer screening during the adverse COVID-19 epidemiological situation
Drzhevetskaya, K. S., & Korzhenkova, G. P. (2021) · Research and Practical Medicine Journal · doi:10.17709/2410-1893-2021-8-3-3 · Cited by 4
The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience
Blaise, D., Berger, P., Mokart, D., Camerlo, J., Fougereau, E., Giovannini, M. F., Houvenaeghel, G. F., Turrini, O., Chabannon, C., Piana, G., et al. (2021) · Clinical Hematology International · doi:10.2991/chi.k.210919.001 · Cited by 3
Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis
Li, Z., Li, Q., Wang, X., Li, S., Chen, W., Jin, X., Liu, X., Dai, Z., Liu, X., Zheng, X., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.767617 · Cited by 3
Self-citation
Healthcare Disparities and Outcomes of Cancer Patients in a Community Setting from a COVID-19 Epicenter
Jones, B. M., Lehrer, E. J., Saraf, A., Shafaee, Z., Salgado, L. R., & Osborn, V. W. (2022) · Current Oncology · doi:10.3390/curroncol29020098 · Cited by 3
Identifying Potential Gene Defect Patterns Related to COVID-19 Based on Pharmacological and Bioinformatics Analysis for Lung Adenocarcinoma
Lou, H., Li, X., Gao, S., Zhang, Y., Chen, H., & Zhai, X. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s356444 · Cited by 3
Self-citation
Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area
Mina, A. A., Galvez, C., Karmali, R., Mulcahy, M. F., Mi, X., Kocherginsky, M., Gurley, M. J., Katam, N., Gradishar, W. J., Altman, J. K., et al. (2022) · Cancers · doi:10.3390/cancers14092209 · Cited by 3
A study of relationship between SARS-CoV-2 antibodies levels and host factors among general population in Zakho City, Iraq
Hussein, N. R., Naqid, I. A., Jamal, S. A., Balatay, A. A., Ibrahim, N., Musa, D. H., & Saleem, Z. S. M. (2022) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v8i4.1256 · Cited by 3
SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge
Hosaka, Y., Yan, Y., Naito, T., Oyama, R., Tsuchiya, K., Yamamoto, N., Nojiri, S., Hori, S., Takahashi, K., & Tabe, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.944369 · Cited by 3
Acute myeloma kidney and SARS-COV2 infection with dialysis need: never say never - a case report
Donati, G., Przygocka, A., Zappulo, F., Vischini, G., Valente, S., & Manna, G. L. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03237-8 · Cited by 3
Cancerona: Challenges of Cancer Management in Times of COVID-19 Pandemic
Ballout, F., Daouk, R., Azar, J. H., Timonian, M. A., Araji, T., Bahmad, H. F., & Abou-Kheir, W. G. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00549-w · Cited by 3
Evolving management strategies for lymphomas during the COVID-19 pandemic
Lang, N., & Kuruvilla, J. G. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1861277 · Cited by 3
The Feasibility and Safety of Routine Thoracic Surgeries in the Low-Risk Areas During the Coronavirus Disease 2019 Pandemic
Wang, Y., Zhang, Y., Bao, F., Hao, X., Yu, F., Lin, B., Gu, Z., & Fang, W. (2021) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2021.100144 · Cited by 3
Self-citation
Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancer
LaPlant, Q. C., Thor, M., Shaverdian, N., Shin, J. Y., Gilbo, P., Luo, J., Gomez, D. R., & Gelblum, D. Y. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.06.002 · Cited by 3
COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario
Sayed, S. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100425 · Cited by 2
Management and Thinking on the Treatment of Cancer Patients During the COVID-19
Pan, S., Jiang, J., Chen, Z., & Yang, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.673360 · Cited by 3
Self-citation
Imaging diagnosis of bronchogenic carcinoma (the forgotten disease) during times of COVID-19 pandemic: Current and future perspectives
Ravikanth, R. (2021) · World Journal of Clinical Oncology · doi:10.5306/wjco.v12.i6.437 · Cited by 3
Preparing for the Next Pandemic: An Asian National Cancer Centers Alliance (ANCCA) Initiative
Gatellier, L., Ong, S. K., Matsuda, T., Ramlee, N., Lau, F. N., Yusak, S., H.R.Soeko Werdi Nintindo, D., Jayusman, A. M., Syarif, A. H., Pradhananga, K. K., et al. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.9.2945 · Cited by 3
Outcomes of Patients with COVID-19 from a Specialized Cancer Care Emergency Room
Nath, S. S., Yadav, N., Derkach, A., Pérez-Johnston, R., Tachiki, L. M. L., Maguire, K., Babar, A., Maloy, M., Klotz, A., Jee, J., et al. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1985134 · Cited by 3
Diabetes mellitus and COVID-19: review of a lethal interaction from the cellular and molecular level to the bedside
Kazem, T. A., Zeylabi, F., Hassan, A. F., Paridar, P., Pezeshki, S. P., & Pezeshki, S. M. S. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2002145 · Cited by 3
An observational study of hospitalized COVID-19 patients with cancer in San Diego county
Hermel, D. J., Cham, J., Bagsic, S. R. S., Hong, L. K., Costantini, C. L., Mason, J. R., Saven, A., & Sigal, D. S. (2022) · Future Oncology · doi:10.2217/fon-2021-1116 · Cited by 3
Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis
Cao, C. Q., Gan, X., Hu, X., Su, Y., Zhang, Y., & Peng, X. (2022) · Aging · doi:10.18632/aging.203945 · Cited by 3
Self-citation
Perceived risk, illness perception and dispositional optimism related to COVID-19 among oncologic outpatients undergoing in-hospital treatments and healthy controls
Gabanelli, P., Monzani, D., Fiabane, E., Quaquarini, E., Frascaroli, M., Balletti, E., Bernardo, A., Teragni, C., Grossi, F., Pravettoni, G., et al. (2022) · Psychology and Health · doi:10.1080/08870446.2022.2065275 · Cited by 3
Recurrent Viral RNA Positivity and Candidiasis Findings in Hospitalized Patients with COVID-19
Naderi, M., Soltani, S. A., Rad, A. T., Mehrbakhsh, Z., Sodagar, S., Tahamtan, A., & Hosseini, H. (2022) · Future Microbiology · doi:10.2217/fmb-2022-0041 · Cited by 3
High mortality in patients with active malignancy and severe COVID-19
Udovica, S., Müser, N., Pechlaner, A., Reichinger, A., Aichinger, C., Strasser‐Weippl, K., Rumpold, H. F., Petzer, A. L., Wöll, E., Hilbe, W., et al. (2022) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-022-00814-9 · Cited by 3
Die Auswirkungen der COVID-19-Pandemie aus der Sicht ambulanter Krebspatienten
Pichler, T., Frank, T., Maier, S., Batenhorst, I., Abawi-Daltrozzo, T., Harbeck, N., Algül, H., Heinemann, V., Hermelink, K., Mumm, F., et al. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1746-7534 · Cited by 3
The effect of music on pain and anxiety in patients receiving chemotherapy during COVID‐19
Koca, G. Y., & Aylaz, R. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13715 · Cited by 3
Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
Tsiakos, K., Gavrielatou, N., Vathiotis, I. A., Chatzis, L. G., Chatzis, S., Poulakou, G., Kotteas, E. A., & Syrigos, N. K. (2022) · Vaccines · doi:10.3390/vaccines10101673 · Cited by 3
Higher Frequency and Poor Prognosis with COVID-19 Associated Cytokine Storm among Cancer Patients: Between Two Fires
Bektaş, M., Koca, N., & İnce, B. (2022) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.4.063 · Cited by 3
Incidence and medical complications of COVID-19 in the total laryngectomy population: A population-based study
Patel, N. D., Cabrera, C. I., Fowler, N., Li, S., Thuener, J. E., Lavertu, P., Teknos, T. N., Rezaee, R. P., & Tamaki, A. (2023) · Oral Oncology · doi:10.1016/j.oraloncology.2023.106353 · Cited by 3
Aptamers as Insights for Targeting SARS-CoV-2
Saygılı, S. K., Szymanowska, A., Lopez‐Berestein, G., Rodriguez‐Aguayo, C., & Amero, P. (2023) · Biologics · doi:10.3390/biologics3020007 · Cited by 4
Palliative care for cancer patients during the COVID‐19 pandemic: A narrative synthesis from 36 studies of 16 countries
Zhao, D., Hu, S., Hu, F., Du, W. D., Tang, W. H., Zhang, W., Chen, H., & Shen, W. (2023) · Journal of Clinical Nursing · doi:10.1111/jocn.16742 · Cited by 3
Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains
Reimann, H., Moosmann, C., Schober, K., Lang, V., Verhagen, J., Zeun, J., Mackensen, A., Kremer, A. N., Völkl, S., & Aigner, M. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152720 · Cited by 2
Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR
Pelcovits, A., Pandita, A., Farmakiotis, D., & Egan, P. (2020) · Leukemia Research · doi:10.1016/j.leukres.2020.106473 · Cited by 3
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19
Shen, C., Li, Q., Wei, Y., Li, Y., Li, J., & Tao, J. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001593 · Cited by 3
COVID-19 – Initial Lockdown: Implications on Cancer Treatment among Palliative Care Outpatients
Jeba, J., Thankachan, A. M., Jacob, A., Kandasamy, R., & Susithra, D. N. (2022) · Indian Journal of Palliative Care · doi:10.25259/ijpc_314_20 · Cited by 2
Navigating uncharted waters: assessing the impact of the COVID-19 pandemic on hematopoietic stem cell transplantation: challenges and innovations
Qureshi, Z. A., Altaf, F., Jamil, A. R., Siddique, R., & Shah, S. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002442 · Cited by 3
The burden of COVID-19 death for different cancer types: a large population-based study
Mo, Y., Wei, D., Chen, X., Zhang, Z., Huo, W., Wu, M., Chen, D., & Yu, J. (2025) · Journal of Global Health · doi:10.7189/jogh.15.04046 · Cited by 2
Self-citation
Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment
Wu, Q., Li, W., Liu, H., Xue, Y., Huang, K., Pourghadamyari, H., & Liu, Z. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101383 · Cited by 2
Bruton’s Tyrosine Kinase Inhibitors: A Versatile Therapeutic Approach for Cancer, Autoimmune Disorders, GVHD and COVID-19
Paliwal, S., Agarwal, U., & Tonk, R. K. (2025) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575409452250815095743 · Cited by 2
Long-term impact of COVID-19 in patients with lung cancer receiving immune checkpoint inhibitors: a multicenter cohort study during Omicron pandemic
Zhang, Y., Li, Y., Zhang, Y., Zhang, T., Li, M., Xin, Y., Wang, T. A., Feng, X., Xu, R., Xia, W., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11544-8 · Cited by 2
Self-citation
Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Lundgren, A., Leach, S., Kaim, J., Dutta, N., Li, Y., Nilsson, F., Jawad, A., Bemark, M., Gisslén, M., Hallqvist, A., et al. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108770 · Cited by 2
A mobile health app for real-time symptom monitoring in patients with cancer during COVID-19: feasibility, acceptability, and utility
Shao, R., Neil, J. M., Chen, M., Hannafon, B. N., Nipp, R. D., Montgomery, A., Frank-Pearce, S. G., Moxley, K. M., Richardson, D. L., Elliott, J., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-15772-2 · Cited by 2
Some RNA Viruses
Shah, Y., & Abuelzein, E. E. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.82983 · Cited by 2
Care Delivery and Treatment Decision Making: Bioethical and Nursing Considerations During and After the COVID-19 Pandemic
Tariman, J. D., Klugman, C. M., Webber‐Ritchey, K. J., & Amer, K. S. (2021) · Clinical journal of oncology nursing · doi:10.1188/21.cjon.61-68 · Cited by 2
COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19
Mbugua, S. N., Njenga, L. W., Odhiambo, R. A., Wandiga, S. O., & Onani, M. O. (2021) · Journal of Chemistry · doi:10.1155/2021/9923518 · Cited by 2
Mortality of COVID-19 pneumonia during anticancer treatment in lung cancer patients
Bursać, D., Zarić, B., Bokan, D., Kovačević, T., Stojšić, V., Petkov, S., Mitrovic, K., & Stojanović, G. M. (2022) · Vojnosanitetski pregled · doi:10.2298/vsp211120018b · Cited by 2
A Systematic Review Assessing the Underrepresentation of Cancer Patients in COVID-19 Trials
Buchrits, S., Fredman, D., Kagan, K. B. T., & Gafter‐Gvili, A. (2022) · Acta Haematologica · doi:10.1159/000524623 · Cited by 2
Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy
Narayan, S., Talwar, V., Goel, V., Chaudhary, K., Sharma, A., Redhu, P., Soni, S., & Jain, A. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i5.339 · Cited by 2

Authors: Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., Yu, T., Wang, L., Wang, H., Liu, Y., Chen, Y., Mei, J., Gao, X., Li, Z., Gan, L., He, C., Li, Z., Shi, Y., Qi, Y., Yang, J., Tenen, D. G., Chai, L., Mucci, L. A., Santillana, M., & Cai, H.
Affiliations: Zhongnan Hospital of Wuhan University (CN)
Boston Children's Hospital (US)
Brigham and Women's Hospital (US)
Wuhan Union Hospital (CN)
Central Hospital of Wuhan (CN)
Huanggang Central Hospital (CN)
Guangzhou Medical University (CN)
Tongji Hospital (CN)
16Department of Radiology, Hubei Cancer Hospital, Wuhan, Hubei, China.
Hubei Cancer Hospital (CN)
Renmin Hospital of Wuhan University (CN)
19Department of Oncology, Wuhan Puren Hospital, Wuhan, Hubei, China.
Xianning Central Hospital (CN)
The Central Hospital of Xiao gan (CN)
22Department of Obstetrics and Gynecology, The People's Hospital of Huangmei, Huangmei, Hubei, China.
Hubei University of Medicine (CN)
Harvard University (US)
Corresponding author: Liu, Miao
Santillana, Mauricio
Cai, Hongbing
ORCID: Liu, Dianbo
Liu, Miao
Zhou, Fuxiang
Li, Guiling
Chen, Zhen
You, Hua
Wu, Meng
Xiong, Yong
Xiong, Huihua
Wang, Chun
Xiong, Fei
Zhang, Yan
Yu, Tingting
Wang, Ling
Wang, Hua
Liu, Yu
Li, Zhuyan
He, Can
Shi, Yuying
Qi, Yuwen
Yang, Jing
Tenen, Daniel G.
Chai, Li
Mucci, Lorelei A.
Santillana, Mauricio
Cai, Hongbing
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2020-06-01
Volume: 10
Issue: 6
Pages: 783-791
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-20-0422
PMC: PMC7309152
OpenAlex: W3015599879
Cited by: 1,589
References: 27
Citations by year: 2026: 16 · 2025: 55 · 2024: 90 · 2023: 218 · 2022: 354 · 2021: 494 · 2020: 356
FWCI: 128.41
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Discovery (publishedVersion)
SSRN Electronic Journal (acceptedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (8197103302/H16)
Singapore Ministry of Health's National Medical Research Council (MOH-STaR18nov-0002)
NIH NHLBI (P01HL095489)
Xiu Research Fund
Institutional Ethics Board of Zhongnan Hospital of Wuhan University (2020029)
Topics: Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
Keywords: COVID-19 pandemic, SARS-CoV-2, cancer patients, disease severity, hematologic malignancies, lung cancer, metastatic cancer, radiotherapy, infection susceptibility
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Disease Outbreaks, Female, Humans, Intensive Care Units, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Respiration, Artificial, Cohort Studies, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks